August 2026 FDA Recall Morphine Sulfate by Fresenius Kabi Usa, Llc
D-0788-2026 - Labeling

This Class I drug recall was voluntarily initiated by Fresenius Kabi Usa, Llc on August 4, 2026 for the product Morphine Sulfate. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0788-2026

Reason for Recall
Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
Initiated
08-04-2026
Reported
08-26-2026
Quantity
625500 syringes

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Fresenius Kabi USA, LLC
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Nationwide within the USA.
Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or Intravenous use, Rx only, Fresenius Kabi, Lake Zurich, IL. Unit of Use NDC Number 76045-004-01; Unit of Sale NDC Number 76045-004-11

Batch or Lot Expiration Information

Lot# : 6402820, Exp. Date 12/2028